Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children

Condition: Small-for-Gestational-Age, Growth Hormone-Deficient and Prader-Willi Children
Journal: Journal of clinical research in pediatric endocrinology
Treatment Used: Growth Hormone Therapy
Number of Patients: 92
Published: February 15, 2019
View publication
Summary: This study evaluated the therapeutic response markers of IGF1/IGFBP3 molar ratio as a tool for assessing the safety of recombinant human growth hormone (rGH) treatment in small-for-gestational-age, growth hormone-deficient, and Prader-Willi Children.

A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.

Condition: Recurrent Acute Myeloid Leukemia (AML)
Journal: American journal of hematology
Treatment Used: Three Novel Regimens
Number of Patients: 90
Published: October 30, 2018
View publication
Summary: This study sought to improve the outcome of relapsed/refractory acute myeloid leukemia (AML), in a phase II trial of three novel regimens.
Showing 1-2 of 2